Ariana Pharma’s Artificial Intelligence, KEM®

Artificial intelligence and PDX mouse models: Ariana Pharma
Artificial Intelligence and PDX mouse models: the winning combination
13/12/2018
Ariana Pharma is a leading digital health company focused on developing advanced therapeutic decision support systems
13/12/2018

Ariana Pharma’s Artificial Intelligence, KEM®

Ariana Pharma’s Artificial Intelligence, KEM®


Ariana Pharma demonstrates use of Artificial Intelligence and PDX mouse models to simulate clinical trial and identify biomarkers of response for combination therapy.

In a collaboration with Oncodesign, Ariana’s KEM was applied to a placebo-controlled experiment with PDX exposed to a combination therapy. KEM® demonstrated the ability of a combined PDX / Artificial Intelligence platform to simulate a clinical study in order to identify biomarkers of drug efficacy and synergy, thus fostering the design of precision medicine clinical trials.

Well characterized patient derived xenograft mouse models (PDX), combined with Ariana Pharma’s Artificial Intelligence, KEM®, enable to integrate and analyze the broad range of generated data and address this challenge.

Identifying biomarkers for patient stratification - Ariana pharma
Figure 1 Identifying biomarkers for patient stratification

Share this